Live Breaking News & Updates on Anthonyj Cataldo

Stay updated with breaking news from Anthonyj cataldo. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

GT Biopharma Announces Positive Preclinical Results For GTB-5550 B7H3 TriKE(TM)

GT Biopharma Announces Positive Preclinical Results For GTB-5550 B7H3 TriKE(TM)
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Anthonyj Cataldo , Merck Keytruda , Beverly Hills , Bristol Myer Squibb , Bristol Myer Squibb Inc , Source Gt Biopharma Inc , Drug Administration , Midam Ventures , Exchange Commission , Midam Ventures Llc Gt Biopharma , University Of Minnesota , Gt Biopharma Inc , Co Inc , Natural Killer , Investigational New Drug , Chief Executive Officer , Securities Act ,

GT Biopharma Provides Second Quarter 2021 Business Update

/PRNewswire/ GT Biopharma, Inc. ("GT Biopharma" or the "Company") (NASDAQ: GTBP), a clinical stage immuno-oncology company focused on developing innovative. ....

France General , Anthonyj Cataldo , Jeffreys Miller , David Castaneda , Beverly Hills , Brendan Payne , Prnewswire Gt Biopharma Inc , Raymond James Human Health Innovation Conference , Stern Investor Relations Inc , Source Gt Biopharma Inc , Strategic Research Agreement , European Society For Medical Oncology Conference , Exchange Commission , University Of Minnesota , Gt Biopharma Inc , Chief Executive , Interim Data Results , Phasei Clinical Trial , Relapsed Acute Myeloid Leukemia , High Risk Myelodysplastic Syndromes , James Human Health Innovation , European Society , Medical Oncology Conference , Cash Increase , Warrant Exercise Proceeds , Securities Act ,

GT Biopharma Provides Second Quarter 2021 Business Update

GT Biopharma Provides Second Quarter 2021 Business Update
biospace.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from biospace.com Daily Mail and Mail on Sunday newspapers.

France General , Anthonyj Cataldo , Jeffreys Miller , David Castaneda , Beverly Hills , Brendan Payne , Raymond James Human Health Innovation Conference , Stern Investor Relations Inc , Source Gt Biopharma Inc , Strategic Research Agreement , European Society For Medical Oncology Conference , Exchange Commission , University Of Minnesota , Gt Biopharma Inc , Chief Executive , Interim Data Results , Phasei Clinical Trial , Relapsed Acute Myeloid Leukemia , High Risk Myelodysplastic Syndromes , James Human Health Innovation , European Society , Medical Oncology Conference , Cash Increase , Warrant Exercise Proceeds , Securities Act , Investor Relations ,

GT Biopharma Provides Second Quarter 2021 Business Update

GT Biopharma Provides Second Quarter 2021 Business Update
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

France General , Anthonyj Cataldo , Jeffreys Miller , David Castaneda , Beverly Hills , Prnewswire Gt Biopharma Inc , Raymond James Human Health Innovation Conference , Source Gt Biopharma Inc , Strategic Research Agreement , European Society For Medical Oncology Conference , Exchange Commission , University Of Minnesota , Gt Biopharma Inc , Chief Executive , Interim Data Results , Phasei Clinical Trial , Relapsed Acute Myeloid Leukemia , High Risk Myelodysplastic Syndromes , James Human Health Innovation , European Society , Medical Oncology Conference , Cash Increase , Warrant Exercise Proceeds , Securities Act , Brendan Paynestern Investor Relations , Media Relations ,

GT Biopharma Announces Positive Preclinical Results For GTB-5550 B7H3 TriKE™

Share this article
Share this article
POTENTIAL TREATMENT OF SEVERAL SOLID TUMOR CANCERS INCLUDING: NON-SMALL CELL LUNG CANCER, SQUAMOUS CELL CARNINOMA, BREAST CANCER, RENAL CANCER, PANCREATIC CANCER, OVARIAN CANCER, LIVER CANCER, COLORECTAL CANCER
BEVERLY HILLS, Calif., Aug. 3, 2021 /PRNewswire/ GT Biopharma, Inc. (NASDAQ: GTBP), a clinical stage biopharmaceutical company focused on developing target-directed, tri-specific Natural Killer (NK) cell engager therapies (TriKE™) incorporating interleukin 15 (IL-15) for the treatment of cancer, announced preclinical results for GTB-5550, its B7H3 TriKE™ product candidate as a prospective therapy for the treatment of several different types of cancers.
GTB-5550 TriKE™ was evaluated in several preclinical models overexpressing B7H3, and was found to be effective at promoting NK cell killing of multiple cancer cell types. B7H3 is over-expressed on several cancer types including non-small cell lung cancer, squ ....

Anthonyj Cataldo , David Castaneda , Merck Keytruda , Beverly Hills , Bristol Myer Squibb , Bristol Myer Squibb Inc , Source Gt Biopharma Inc , Drug Administration , Exchange Commission , University Of Minnesota , Gt Biopharma Inc , Co Inc , Natural Killer , Investigational New Drug , Chief Executive Officer , Securities Act , Media Relations , டேவிட் கஷ்டனேடா , பெவர்லி மலைகள் , பிரிஸ்டல் மையர் ஸ்க்விப்ப் , பரிமாற்றம் தரகு , பல்கலைக்கழகம் ஆஃப் மினசோட்டா , இணை இன்க் , இயற்கை கில்லர் , தலைமை நிர்வாகி அதிகாரி , பத்திரங்கள் நாடகம் ,